Milk: Whole, Skim or Something In Between? - Frankly Speaking EP 162
Guest: Susan Feeney, DNP, FNP-BCMusic Credit: Richard Onorato
Frankly Speaking, Live! This episode, recorded live from Pri-Med South, will review four recent publications that help guide milk consumption in children and adults.
Updates From the 2021 EASD and ADA Annual Meetings on Dual GIP/GLP-1 RA Therapy: What You Should Know (Module 3)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
The Role of GIP and GLP-1 in the Pathophysiology of T2DM and Why it Matters (Module 2)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
Addressing “Diabesity”: Weight Loss as a Key Therapeutic Goal in the Management of T2DM (Module 1)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
This session will cover some new data regarding treatment of type 2 diabetes: the GRADE study, SURPASS phase 3 program, the STEP program for treatment of obesity. It will also provide an update on studies using SGLT2 inhibitors and GLP 1 receptor agonists in people with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease.
Boosting Weight Loss with Medications: New Support for GLP-1 RAs - Frankly Speaking EP 270
Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato
You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.
More Than Beauty: Length and Quality of Sleep and Its Impact on CV Risk Factors in Teens - Frankly Speaking EP 82
It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors. Guest: Susan Feeney, DNP, FNP-BC
It has been fairly established that short duration of sleep is associated with obesity in teens and adults; however, the impact of quantity and quality of sleep has not been as well established. A cross-sectional study by Feliciano et al. found that longer and better sleep was associated with better cardiometabolic profiles in early adolescence – independent of other factors.
‘Bridging the Gap: Conversations with Dr. Hall’ Garners Positive Response From Primary Care Clinicians
Leading CME Provider Heralded for Excellence in Collaboration and Educational Design
This presentation will provide an overview of the scientific evidence supporting the utility of exercise in maintaining health and decreasing the risk of chronic diseases including diabetes, hypertension, cancer, coronary heart disease, depression. In addition, we will review the evidence showing that exercise can mitigate the risk incurred by diseases like diabetes and hypertension. Then we will discuss a practical approach for discussing exercise with patients/clients and helping patients achieve successful outcomes with lifestyle modification.
In each episode of Bridging the Gap, Gregory L. Hall, MD, educates primary care clinicians on different aspects of African American health in order to help improve patient outcomes. Topics include cancer screening and prevention, communication and bias diabetes, dietary differences, hypertension, improving adherence and compliance, obesity, psychiatric disorders, and renal disease.
Breastfeeding Supplemented with Formula; When Is It the Right Thing to Do? - Frankly Speaking EP 80
Breastfeeding exclusively in the first six months of life is widely recommended. However, in this study of newborns who were losing weight because their mother’s milk had not yet come in, post-breastfeeding supplementation improved weight and did not alter breastfeeding rates at one month. Guest: Susan Feeney, DNP, FNP-BC
Breastfeeding exclusively in the first 6 months of life is widely recommended. However, in this study of newborns who were losing weight because their mother’s milk had not yet come in, post-breastfeeding supplementation improved weight and did not alter breast feeding rates at one month.